NAMD Submits Comments on Medicaid Drug Rebate Program Proposed Rule
On July 25, NAMD submitted comments on CMS's proposed rule on the Medicaid Drug Rebate Program (MDRP).
Letter ·
NAMD Highlights Impact of 21st Century Cures on Medicaid
In April 2015, NAMD provided input on the draft 21st Century Cures legislation to House lawmakers including challenges the draft legislation would present for Medicaid programs across the country.
In April 2015, NAMD provided input on the draft 21st Century Cures legislation to House lawmakers. The letter highlights the existing challenges in Medicaid reimbursement for high-cost specialty and curative therapies, more of which would be brought to market under the proposed law. NAMD recommends Congress modernize Medicaid’s reimbursement tools to match its emphasis on drug therapy innovation.
Related resources
Prescription Drug Spending: What’s Coming Next for Medicaid and How Can States Prepare?
Experts at the NAMD Fall Conference discussed challenges with high-cost drugs.
NAMD Comments on Medicare’s Proposed Coverage Determination for Alzheimer’s Drug
On February 9, 2022, NAMD submitted comments on Medicare’s proposed National Coverage Determination (NCD) of Coverage with Evidence...
Stay Informed
Drop us your email and we’ll keep you up-to-date on Medicaid issues.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.